Nanoemulsion In Pharmaceuticals

Nanoemulsion Based Targeting in Cancer Therapeutics

A major hurdle in cancer diagnosis and therapy is the targeted and efficacious delivery of agents to the tumor site, while avoiding adverse damage resulting from systemic administration. While systemic drug delivery already hinges largely on physicochemical properties of the drug, such as size, diffusivity, and plasma protein binding affinity, tumors possess a dense, heterogeneous vasculature a...

Genotoxic Impurities in Pharmaceuticals

Genotoxic compounds induce genetic mutations and/or chromosomal rearrangements and can therefore act as carcinogenic compounds (McGovern and Jacobson-Kram, 2006). These compounds cause damage to DNA by different mechanisms such as alkylation or other interactions that can lead to mutation of the genetic codes. In general, chemists employ the terms "genotoxic" and "mutagenic" synonymously; howev...

Pharmaceuticals in the Environment.qxp

Recently the concerns about environmental contaminants has widened to include not just persistent organic pollutants like pesticides (POPs) but pharmaceuticals and personal care products (PPCPs) as well. PPCPs encompass a broad class of chemicals, ranging from over-the-counter and prescription drugs, to sunscreen and fragrances. Unlike priority pollutants, most PPCPs are not lipophilic, so they...

Stretching Folding Instablility and Nanoemulsion

Industry Dynamics in Pharmaceuticals

Pharmaceuticals is a relatively large and mature industry, and of growing significance. The industry has stimulated extensive research on determinants of its growth and development. Specifically, the distribution of firm size has attracted significant attention, due to its relevance as an indicator of degree of industrial concentration. A large part of this literature has focused, since the ear...